Balance Sheet

Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Outstanding Shares Outstanding Shares Repurchased

Iradimed (IRMD) Shares Issued (2016 - 2024)

Iradimed has reported Shares Issued over the past 10 years, most recently at $25704.0 for Q4 2024.

Quarterly Shares Issued fell 84.83% to $25704.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $195109.0 through Dec 2024, down 20.09% year-over-year, with the annual reading at $29000.0 for FY2024, 83.59% down from the prior year.
Shares Issued was $25704.0 for Q4 2024 at Iradimed, down from $169403.0 in the prior quarter.
Over five years, Shares Issued peaked at $931732.0 in Q3 2020 and troughed at $1.0 in Q2 2022.
The 5-year median for Shares Issued is $67434.0 (2021), against an average of $191984.3.
Year-over-year, Shares Issued crashed 100.0% in 2022 and then skyrocketed 16940200.0% in 2023.
A 5-year view of Shares Issued shows it stood at $931732.0 in 2020, then tumbled by 42.3% to $537627.0 in 2021, then crashed by 100.0% to $1.0 in 2022, then skyrocketed by 16940200.0% to $169403.0 in 2023, then crashed by 84.83% to $25704.0 in 2024.
Per Business Quant, the three most recent readings for IRMD's Shares Issued are $25704.0 (Q4 2024), $169403.0 (Q4 2023), and $2.0 (Q3 2023).